|
1
|
Russo A, Ficili B, Candido S, Pezzino FM,
Guarneri C, Biondi A, Travali S, McCubrey JA, Spandidos DA and
Libra M: Emerging targeted therapies for melanoma treatment
(Review). Int J Oncol. 45:516–524. 2014.PubMed/NCBI
|
|
2
|
Voskoboynik M and Arkenau HT: Combination
therapies for the treatment of advanced melanoma: A review of
current evidence. Biochem Res Int. 2014:3070592014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Anand P, Sundaram C, Jhurani S,
Kunnumakkara AB and Aggarwal BB: Curcumin and cancer: An 'old-age'
disease with an 'age-old' solution. Cancer Lett. 267:133–164. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chatterjee SJ and Pandey S:
Chemo-resistant melanoma sensitized by tamoxifen to low dose
curcumin treatment through induction of apoptosis and autophagy.
Cancer Biol Ther. 11:216–228. 2011. View Article : Google Scholar
|
|
5
|
Siwak DR, Shishodia S, Aggarwal BB and
Kurzrock R: Curcumin-induced antiproliferative and proapoptotic
effects in melanoma cells are associated with suppression of
IkappaB kinase and nuclear factor kappaB activity and are
independent of the B-Raf/mitogen-activated/extracellular
signal-regulated protein kinase pathway and the Akt pathway.
Cancer. 104:879–890. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zheng M, Ekmekcioglu S, Walch ET, Tang CH
and Grimm EA: Inhibition of nuclear factor-kappaB and nitric oxide
by curcumin induces G2/M cell cycle arrest and apoptosis in human
melanoma cells. Melanoma Res. 14:165–171. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Odot J, Albert P, Carlier A, Tarpin M,
Devy J and Madoulet C: In vitro and in vivo anti-tumoral effect of
curcumin against melanoma cells. Int J Cancer. 111:381–387. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Marín YE, Wall BA, Wang S, Namkoong J,
Martino JJ, Suh J, Lee HJ, Rabson AB, Yang CS, Chen S, et al:
Curcumin downregulates the constitutive activity of NF-kappaB and
induces apoptosis in novel mouse melanoma cells. Melanoma Res.
17:274–283. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Oelkrug C, Lange CM, Wenzel E, Fricke S,
Hartke M, Simasi J and Schubert A: Analysis of the tumoricidal and
anti-cachectic potential of curcumin. Anticancer Res. 34:4781–4788.
2014.PubMed/NCBI
|
|
10
|
Anand P, Kunnumakkara AB, Newman RA and
Aggarwal BB: Bioavailability of curcumin: Problems and promises.
Mol Pharm. 4:807–818. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu H, He Z and Simon HU: Targeting
autophagy as a potential therapeutic approach for melanoma therapy.
Semin Cancer Biol. 23:352–360. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hönscheid P, Datta K and Muders MH:
Autophagy: Detection, regulation and its role in cancer and therapy
response. Int J Radiat Biol. 90:628–635. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chu YL, Raghu R, Lu KH, Liu CT, Lin SH,
Lai YS, Cheng WC, Lin SH and Sheen LY: Autophagy therapeutic
potential of garlic in human cancer therapy. J Tradit Complement
Med. 3:159–162. 2013. View Article : Google Scholar
|
|
14
|
Thorburn A, Thamm DH and Gustafson DL:
Autophagy and cancer therapy. Mol Pharmacol. 85:830–838. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Alifrangis C, Koizia L, Rozario A, Rodney
S, Harrington M, Somerville C, Peplow T and Waxman J: The
experiences of cancer patients. QJM. 104:1075–1081. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Slevin ML, Stubbs L, Plant HJ, Wilson P,
Gregory WM, Armes PJ and Downer SM: Attitudes to chemotherapy:
Comparing views of patients with cancer with those of doctors,
nurses, and general public. BMJ. 300:1458–1460. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Thornton M, Parry M, Gill P, Mead D and
Macbeth F: Hard choices: A qualitative study of influences on the
treatment decisions made by advanced lung cancer patients. Int J
Palliat Nurs. 17:68–74. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chinembiri TN, du Plessis LH, Gerber M,
Hamman JH and du Plessis J: Review of natural compounds for
potential skin cancer treatment. Molecules. 19:11679–11721. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stewart ZA, Westfall MD and Pietenpol JA:
Cell-cycle dysregulation and anticancer therapy. Trends Pharmacol
Sci. 24:139–145. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cho JH, Lee JG, Yang YI, Kim JH, Ahn JH,
Baek NI, Lee KT and Choi JH: Eupatilin, a dietary flavonoid,
induces G2/M cell cycle arrest in human endometrial cancer cells.
Food Chem Toxicol. 49:1737–1744. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rozzo C, Fanciulli M, Fraumene C, Corrias
A, Cubeddu T, Sassu I, Cossu S, Nieddu V, Galleri G, Azara E, et
al: Molecular changes induced by the curcumin analogue D6 in human
melanoma cells. Mol Cancer. 12:372013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang L, Wang H, Xu J, Zhu J and Ding K:
Inhibition of cathepsin S induces autophagy and apoptosis in human
glioblastoma cell lines through ROS-mediated PI3K/AKT/mTOR/p70S6K
and JNK signaling pathways. Toxicol Lett. 228:248–259. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ornelas IM, Silva TM, Fragel-Madeira L and
Ventura AL: Inhibition of PI3K/Akt pathway impairs G2/M transition
of cell cycle in late developing progenitors of the avian embryo
retina. PLoS One. 8:e535172013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hennessy BT, Smith DL, Ram PT, Lu Y and
Mills GB: Exploiting the PI3K/AKT pathway for cancer drug
discovery. Nat Rev Drug Discov. 4:988–1004. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin HP, Jiang SS and Chuu CP: Caffeic acid
phenethyl ester causes p21 induction, Akt signaling reduction, and
growth inhibition in PC-3 human prostate cancer cells. PLoS One.
7:e312862012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou HY and Wong AS: Activation of p70S6K
induces expression of matrix metalloproteinase 9 associated with
hepatocyte growth factor-mediated invasion in human ovarian cancer
cells. Endocrinology. 147:2557–2566. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Berven LA, Willard FS and Crouch MF: Role
of the p70S6K pathway in regulating the actin
cytoskeleton and cell migration. Exp Cell Res. 296:183–195. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Corazzari M, Fimia GM, Lovat P and
Piacentini M: Why is autophagy important for melanoma? Molecular
mechanisms and therapeutic implications. Semin Cancer Biol.
23:337–343. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu S, Wang X, Chen J and Chen Y: Autophagy
of cancer stem cells is involved with chemoresistance of colon
cancer cells. Biochem Biophys Res Commun. 434:898–903. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Han Z, Jing Y, Xia Y, Zhang S, Hou J, Meng
Y, Yu F, Liu X, Wu M, Zhang P, et al: Mesenchymal stem cells
contribute to the chemoresistance of hepatocellular carcinoma cells
in inflammatory environment by inducing autophagy. Cell Biosci.
4:222014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ge J and Chen Z, Huang J, Chen J, Yuan W,
Deng Z and Chen Z: Upregulation of autophagy-related gene-5 (ATG-5)
is associated with chemoresistance in human gastric cancer. PLoS
One. 9:e1102932014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Armstrong JL, Corazzari M, Martin S,
Pagliarini V, Falasca L, Hill DS, Ellis N, Al Sabah S, Redfern CP,
Fimia GM, et al: Oncogenic B-RAF signaling in melanoma impairs the
therapeutic advantage of autophagy inhibition. Clin Cancer Res.
17:2216–2226. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Janku F, McConkey DJ, Hong DS and Kurzrock
R: Autophagy as a target for anticancer therapy. Nat Rev Clin
Oncol. 8:528–539. 2011. View Article : Google Scholar : PubMed/NCBI
|
